Literature DB >> 10758224

Pathogenetic potential of leukocytes in diabetic retinopathy.

K Miyamoto1, Y Ogura.   

Abstract

Recently, increasing interest has been directed toward the role of leukocytes in microvascular disorders including diabetic retinopathy because of their large cell volume, high cytoplasmic rigidity, natural tendency to stick to the vascular endothelium, and capacity to generate toxic superoxide radicals and proteolytic enzymes. Leukocytes in diabetes are reported to be less deformable and more activated, and may be involved in capillary non-perfusion, endothelial cell damage, and vascular leakage in the retinal microcirculation. In fact, histological studies show many capillary occlusions by leukocytes and capillary dropout or degeneration associated with leukocytes in the diabetic retina. Serial acridine orange leukocyte fluorography and fluorescein angiography studies also identify trapped leukocytes directly associated with areas of downstream non-perfusion in the diabetic retinal microcirculation. More recent studies suggest that adhesion molecules may mediate retinal leukocyte stasis (leukostasis) in diabetes and a reduction in the leukostasis by anti-adhesion antibodies can suppress retinal vascular leakage. In addition, some agents inhibiting leukostasis are reported to improve retinal abnormalities induced by diabetes. Thus, leukostasis in the retinal microcirculation can be a new promising target in the treatment of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10758224     DOI: 10.3109/08820539909069542

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  33 in total

Review 1.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  Reduction of experimental diabetic vascular leakage and pericyte apoptosis in mice by delivery of αA-crystallin with a recombinant adenovirus.

Authors:  Y H Kim; S Y Park; J Park; Y S Kim; E M Hwang; J Y Park; G S Roh; H J Kim; S S Kang; G J Cho; W S Choi
Journal:  Diabetologia       Date:  2012-07-08       Impact factor: 10.122

3.  Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment.

Authors:  Ashay D Bhatwadekar; Viral S Kansara; Thomas A Ciulla
Journal:  Expert Opin Investig Drugs       Date:  2020-01-31       Impact factor: 6.206

Review 4.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Disruption of the retinal parafoveal capillary network in type 2 diabetes before the onset of diabetic retinopathy.

Authors:  Johnny Tam; Kavita P Dhamdhere; Pavan Tiruveedhula; Silvestre Manzanera; Shirin Barez; Marcus A Bearse; Anthony J Adams; Austin Roorda
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

6.  Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.

Authors:  Aniruddha C Amrite; Surya P Ayalasomayajula; Narayan P S Cheruvu; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

7.  Effect of diabetes on transscleral delivery of celecoxib.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

8.  Pharmacologic therapies for diabetic retinopathy and diabetic macular edema.

Authors:  Ehud Rechtman; Alon Harris; Hanna J Garzozi; Thomas A Ciulla
Journal:  Clin Ophthalmol       Date:  2007-12

Review 9.  Impact of Diabetic Complications on Balance and Falls: Contribution of the Vestibular System.

Authors:  Linda J D'Silva; James Lin; Hinrich Staecker; Susan L Whitney; Patricia M Kluding
Journal:  Phys Ther       Date:  2015-08-06

10.  Nerve growth factor in diabetic retinopathy: beyond neurons.

Authors:  Barbara A Mysona; Ahmed Y Shanab; Sally L Elshaer; Azza B El-Remessy
Journal:  Expert Rev Ophthalmol       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.